Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Abstract Multiple sclerosis is an inflammatory neurodegenerative disease of the central nervous system (CNS) and the most frequent cause of non-traumatic disability in adults in the Western world. Currently, several drugs have been approved for the treatment of multiple sclerosis. While the newer dr...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2018-12-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s40120-018-0120-1 |